Press Releases - Lupin
November 28, 2024 Lupin Receives Tentative Approval from U.S. FDA for Sitagliptin and Metformin Hydrochloride Tablets
Lupin up 2%, hits new high on buying Eli Lilly's diabetes drug ...
Dec 31, 2024 · Home / Markets / News / Lupin up 2%, hits new high on buying Eli Lilly's diabetes drug Huminsulin. Lupin up 2%, hits new high on buying Eli Lilly's diabetes drug Huminsulin ... Lupin's management believes the company’s product pipeline for the US in FY26 will increase US sales to $1 billion in CC terms. Hence, the brokerage firm expects Lupin ...
Shares of Lupin Ltd reach all-time high price on acquiring …
Dec 31, 2024 · Shares of Lupin Ltd surged 2.38 per cent to ₹2,364.65 on the BSE at 11.27 AM and it reached an all-time high of ₹2,372.55 during the session.. Lupin Ltd., a global pharmaceutical company ...
Lupin Announcement, Latest News on Lupin - The Economic Times
Dec 27, 2024 · Lupin Share Price: Indian pharmaceutical giant Lupin gained US FDA approval for its generic version of Gilead Sciences' HIV drug Descovy. This win grants Lupin 180 days of shared exclusivity in the US market, a significant boost for the company.
Lupin shares in focus after FDA approval for generic HIV tablets
Dec 19, 2024 · Lupin Share Price: Indian pharmaceutical giant Lupin gained US FDA approval for its generic version of Gilead Sciences' HIV drug Descovy. This win grants Lupin 180 days of shared exclusivity in the US market, a significant boost for the company.
Lupin gets USFDA approval for key respiratory drug gSpiriva
Jun 22, 2023 · Drugmaker Lupin Ltd. has received approval from the USFDA for its key respiratory drug gSpiriva, confirming a CNBC-TV18 newsbreak earlier in the day. The company is the first generic player to get approval for this blockbuster drug.
Troubled Lupin suspends manufacturing of drugs bound for US
Nov 8, 2022 · Indian generics manufacturer Lupin has suspended production of drugs bound for the U.S. from a troubled active pharmaceutical ingredient plant in India, according to an FDA warning letter.
Lupin Central
The Lupin Central homepage! Here you will find an overview of all of the latest news updates, featured articles and more.
Lupin stock rallies 7%, hits multi-year high on healthy earnings ...
Jul 4, 2024 · Shares of Lupin hit a multi-year high at Rs 1,749, soaring 7 per cent on the BSE in Thursday’s intra-day trade backed by heavy volumes on expectation of healthy earnings. The stock of drug maker surpassed its previous high of Rs 1,727.90 touched on May 22, 2024.
Lupin | Latest & Breaking News on Lupin | Photos, Videos, …
EPFO 3.0: Subscribers could be allowed to withdraw PF using ATMs? Get all latest & breaking news on Lupin. Watch videos, top stories and articles on Lupin at moneycontrol.com.